On 19 January, the EU Court of Justice made a ruling on the interpretation of EU regulations for products on the drug/device borderline that Erik Vollebregt, legal medtech expert and founding partner at Axon Lawyers (Netherlands), has criticized for placing a “negative burden of proof” on manufacturers.
The court’s ruling came about in light of two separate cases of nasal drops/sprays, referred to in the court...